The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Ionicon Launches Autosampler for High Throughput PTR-MS (2016-04-22)
Automated real-time VOC trace gas analysis of large sample quantities with IONICON PTR-MS The real-time measuring capability of a PTR-MS trace gas analyzer is ideally suited for continuous VOC monitoring but also for rapid analysis of discrete samples within s...
- Ablynx to Receive an €8m Phase 1 Milestone from Boehringer (2016-04-21)
Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] and Boehringer Ingelheim today announced the initiation of a Phase I study to evaluate the safety, tolerability and pharmacokinetics of single ascending doses of an anti-CX3CR1 Nanobody®, administered intravenously. The ...
- MorphoSys: Novartis’ Bimagrumab Phase2b/3 Misses Endpoint (2016-04-21)
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that its partner Novartis has confirmed that a phase 2b/3 study examining bimagrumab (BYM338) in sporadic Inclusion Body Myositis (sIBM) did not meet its primary endpoint. Data are ...
- Aptuit Announces Acquisition of Exquiron Biotech AG (2016-04-21)
Aptuit, LLC today announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a leading specialist Contract Research Organization dedicated to early phase drug discovery solutions. Lo...
- Illumina Files Patent Infringement Suit against Genoma SA (2016-04-21)
Illumina, Inc. (NASDAQ: ILMN) today announced that it, and its wholly owned subsidiary, Verinata Health, Inc. (together “Illumina”), filed a patent infringement suit against Genoma SA in the Federal Patent Court in Switzerland. Illumina is seeking all available rem...
- Second Genome: $42.6m Series B Round Led by Pfizer and Roche (2016-04-20)
Financing to expand the Second Genome Microbiome Discovery Platform and accelerate the clinical development of pipeline programs Second Genome, Inc., a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, t...
- Saphetor Signs Collaboration with CHUV Lausanne (2016-04-20)
Agreement covers analysis of CHUV NGS data in research and clinical applications for endocrinology, metabolism and diabetes Saphetor SA, a Swiss precision medicine company working at the cutting edge of clinically meaningful genome-scale analysis based on Next...
- SBP and GSK Create New Center for Translational Neuroscience (2016-04-20)
Sanford Burnham Prebys Medical Discovery Institute (SBP), a leading fundamental and translational research institute, and GlaxoSmithKline (GSK), a global pharmaceutical company, have announced the creation of the SBP-GSK Center for Translational Neuroscience. The n...
- Enterome Raises €14.5m in Series C Financing Round (2016-04-20)
ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that it has raised €14.5 million in a Series C financing round. The round was led by existing investors, such as Seventure (including from...
- R-Biopharm to Develop Molecular CDx for HMNC Brain Health (2016-04-19)
R-Biopharm AG announced today it has entered into a collaboration agreement with HMNC Brain Health in the field of complementary diagnostics. Under this agreement R-Biopharm AG will develop an in vitro PCR (Polymerase Chain Reaction) based genetic test. The goal...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to email@example.com and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]